Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Xiamen Hanrui Touzi Guanli Youxian Gongsi

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 2
Rounds per year 0.50
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon

Areas of investment

  • SaaS
  • Big Data
  • Financial Services
  • Medical Device
  • Electronic Health Record (EHR)

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Xiamen Hanrui Touzi Guanli Youxian Gongsi:
Typical Co-investors
Xiamen Hanrui Touzi Guanli Youxian Gongsi is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Xiamen Hanrui Touzi Guanli Youxian Gongsi:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Altos Venture Allschwil, Basel-Landschaft, Switzerland
Baili Capital -
Bualuang Ventures -
CW Ventures New York, New York, United States
Guangyao Tianrun Beijing, Beijing, China
Hongshan Fund China, Ürümqi, Xinjiang
MAD Ventures British Columbia, Canada, Victoria
Miyazaki Taiyo Capital Japan, Miyazaki, Miyazaki Prefecture
Nordic Consumer Health Nacka, Stockholms Lan, Sweden
Phoenix Fund Beijing, Beijing, China
Pique Ventures British Columbia, Canada, Vancouver
Rittenhouse Ventures Pennsylvania, Philadelphia, United States
SCP Private Equity Partners Malvern, Pennsylvania, United States
Shanghai Furong Investment China, Shanghai
Slack Venture Capital England, Nottingham, United Kingdom
TMT Ventures Karachi, Pakistan, Sindh
Wikow Ventures Hallands Lan, Kullavik, Sweden
Wynnefield Capital Advisors New York, New York, United States
XLR8UH Hawaii, Honolulu, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HAFEISI

Cosmetics
Electronic Health Record (EHR)
Health Care
Manufacturing
Medical Device
Sales
$463K01 Sep 2016 Siming, China

Big Data
Financial Services
SaaS
$1M01 Feb 2016 China, Shanghai

Big Data
Financial Services
SaaS
$1M01 Jun 2015 China, Shanghai

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Xiamen Hanrui Touzi Guanli Youxian Gongsi?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 1M
Rounds per year 0.50
Peak activity year 2016
Lead investments 0
Follow on index 0.33
Exits 1
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HAFEISI

Cosmetics
Electronic Health Record (EHR)
Health Care
Manufacturing
Medical Device
Sales
$463K01 Sep 2016 Siming, China

Big Data
Financial Services
SaaS
$1M01 Feb 2016 China, Shanghai

Big Data
Financial Services
SaaS
$1M01 Jun 2015 China, Shanghai
Crunchbase icon

Content report

The following text will be sent to our editors: